Spartalizumab Antibody
Spartalizumab (PDR001) is a humanized anti-PD-1 monoclonal antibody that potently inhibits PD-1/PD-L1/PD-L2 interactions. It is utilized in research, including in vitro and in vivo studies, for investigating immunotherapies against cancers such as anaplastic thyroid carcinoma (ATC) .
Product Specifications
Product Name Alternative
PD-L1, PDL1, PDR 001, PDR001, PDR-001, Spartalizumab, Spartalizumab (anti-PD-1), PD1/PDL1, PD1, PD-1, anti-PD-1
Target
PD-1/PD-L1
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Concentration
2.56 mg/mL
Purity
95.10% (May vary between batches)
Molecular Weight
145.74 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
EK11149 48 Tests
Guinea pig Amyloid beta A4 protein (APP) ELISA Kit
Sign In for Pricing
View Details 
![TGF beta 1 (TGFB1) Mouse Monoclonal Antibody [Clone ID: OTI1E12]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
TA506585S 30 µL
TGF beta 1 (TGFB1) Mouse Monoclonal Antibody [Clone ID: OTI1E12]
Sign In for Pricing
View Details 